[Spontaneous intracranial hypotension--a treatable cause of headache].

M. Niinivirta,R. Marttila,K. Koski

Abstract:

What problem does this paper attempt to address?

Neuropsychology practice guidance for the neuropsychiatric aspects of Long COVID

Christine H. Koterba,Ciaran M. Considine,Jacqueline H. Becker,Kristen R. Hoskinson,Rowena Ng,Gray Vargas,Michael R. Basso,Antonio Enrique Puente,Sara M. Lippa,Douglas M. Whiteside

DOI: https://doi.org/10.1080/13854046.2024.2392943

2024-08-26

The Clinical Neuropsychologist

Abstract:Objective: The coronavirus disease-2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has had a profound global impact on individual health and well-being in adults and children. While most fully recover from COVID-19, a relatively large subgroup continues to experience persistent physical, cognitive, and emotional/behavioral symptoms beyond the initial infection period. The World Health Organization has termed this phenomenon "Post-COVID-19 Condition" (PCC), better known as "Long COVID." Due to the cognitive and psychosocial symptoms, neuropsychologists often assess and recommend treatment for individuals with Long COVID. However, guidance for neuropsychologists' involvement in clinical care, policy-making, and research has not yet been developed. The authors of this manuscript convened to address this critical gap and develop guidance for clinical neuropsychologists working with patients presenting with Long COVID. Method: Authors include pediatric and adult neuropsychologists with expertise in Long COVID and behavioral health. All authors have been engaged in clinical and research efforts examining the impact of COVID-19. Authors summarized the literature-to-date pertinent to the neuropsychiatric sequelae of Long COVID and developed guidance for neuropsychologists working with individuals with Long COVID. Conclusions: Research findings regarding neuropsychiatric symptoms associated with Long COVID are mixed and limited by methodological differences. As they practice and conduct research, neuropsychologists should remain mindful of the evolving and tenuous nature of the literature.

psychology, clinical,clinical neurology
Long COVID neuropsychological follow-up: Is cognitive rehabilitation relevant?

Lucia Willadino Braga,Sandro Barbosa Oliveira,Andrea Suhet Moreira,Maria Eloá Moreira da Silva Martins Pereira,Andrea Simoes Serra Serio,Virgínia da Silva Carneiro,Luciana de Figueiredo Pereira Freitas,Lígia Maria do Nascimento Souza

DOI: https://doi.org/10.3233/nre-230212

2023-12-20

Neurorehabilitation

Abstract:BACKGROUND: Duration of neuropsychological disorders caused by long COVID, and the variables that impact outcomes, are still largely unknown. OBJECTIVE: To describe the cognitive profile of patients with long COVID post-participation in a neuropsychological rehabilitation program and subsequent reassessment and identify the factors that influence recovery. METHODS: 208 patients (mean age of 48.8 y.o.), mostly female, were reevaluated 25 months after their first COVID infection and 17 months after their initial evaluation. Patients underwent subjective assessment, Barrow Neurological Institute Screen for Higher Cerebral Functions (BNIS), Phonemic Verbal Fluency and Clock Drawing tests (NEUPSILIN) for executive functions, Hospital Anxiety and Depression Scale (HADS) and WHOQol-Bref. RESULTS: We noted a discrete improvement of neuropsychological symptoms 25 months after the acute stage of COVID-19; nonetheless, performance was not within the normative parameters of standardized neuropsychological testing. These results negatively impact QoL and corroborate patients' subjective assessments of cognitive issues experienced in daily life. Improvement was seen in those who participated in psychoeducational neuropsychological rehabilitation, had higher levels of education, and lower depression scores on the HADS. CONCLUSION: Our data reveal the persistence of long-term cognitive and neuropsychiatric disorders in patients with long COVID. Neuropsychological rehabilitation is shown to be important, whether in-person or online.

clinical neurology,rehabilitation
A Practical Approach to Tailor the Term Long COVID for Diagnostics, Therapy and Epidemiological Research for Improved Long COVID Patient Care

Kathryn Hoffmann,Michael Stingl,Liam O'Mahony,Eva Untersmayr

DOI: https://doi.org/10.1007/s40121-024-01025-x

Abstract:The term long COVID (LC) effectively describes the broad long-term disease burden of severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) infections, encompassing individual suffering and significant socioeconomic impacts. However, its general use hampers precise epidemiological research, diagnostics and therapeutic strategies. Misinterpretations occur, for example, when population surveys are compared to studies using health record data, because both refer to these data as LC. This also emphasizes the need for different terminology. The National Institute for Health and Care Excellence (NICE) rapid guideline differentiates ongoing symptomatic COVID-19 from post-COVID conditions, yet real-world observations challenge these two subgroup definitions. We propose refining the term LC into three subgroups: ongoing symptomatic COVID-19, SARS-CoV-2 induced or exacerbated diseases and post-acute COVID condition. This stratification aids targeted diagnostics, treatment and epidemiological research. Subgroup-specific documentation using the International Classification of Diseases, Tenth Revision (ICD-10) codes ensures accurate tracking and understanding of long-term effects. The subgroup of post-acute COVID condition again includes various symptoms, syndromes and diseases like post-exertional malaise (PEM), dysautonomia or cognitive dysfunctions. In this regard, differentiation, especially considering PEM, is crucial for effective diagnostics and treatment.
A practical framework for Long COVID treatment in primary care

W Michael Brode,Esther Melamed

DOI: https://doi.org/10.1016/j.lfs.2024.122977

2024-10-01

Abstract:Long COVID is a complex, multisystem illness with a poorly understood pathophysiology, absence of specific diagnostic tests or criteria, or evidence-based treatments. With over 200 identified symptoms and approximately 10% of COVID-19 cases resulting in Long COVID, it is a challenge to provide comprehensive treatment at a scale commensurate with the illness burden. The diverse manifestations of Long COVID, encompassing numerous medical specialties, typically place primary care providers (PCPs) at the forefront of management, navigating an evolving landscape of research and lack of evidence-based guidelines. This paper presents a pragmatic, structured framework for Long COVID management in primary care, integrating current knowledge and best practices. The approach is individualized, addressing Long COVID's broad symptomatology through a four-step framework. The first step focuses on energy management strategies, emphasizing the prevention of post-exertional malaise, a cardinal feature of Long COVID. The second step, intentional rehabilitation, employs carefully titrated multidisciplinary modalities to address physical, cognitive, and emotional domains. The third step utilizes symptomatic management through both pharmacological and non-pharmacological interventions, targeting debilitating symptoms like fatigue, insomnia, and chronic pain. The fourth step outlines an approach to trialing experimental, targeted therapies that may impact Long COVID's underlying pathophysiology. These treatments, while experimental and lacking quality evidence in Long COVID, may be available off-label on an individual basis following a thorough risk-benefit discussion. This stepwise framework can equip PCPs to effectively address the most common and disabling symptoms of Long COVID, individualize care, and remain attuned to the evolving scientific understanding of the condition.
Assessing Neuropsychiatric Symptoms in Long COVID: A Retrospective Cohort Study from a South Texas Long COVID Clinic

Anne Marie Wells,Summer Rolin,Barbara F Robles-Ramamurthy,Gabriela Gibson-Lopez,Martin Goros,Jonathan A Gelfond,Stephen Gelfond,Philip Balfanz,Melissa Deuter,Donald McGeary,Monica Verduzco Gutierrez

DOI: https://doi.org/10.1101/2024.11.03.24316669

2024-11-04

Abstract:Long COVID, previously known as Post-Acute Sequelae of SARS-CoV-2 (PASC), refers to prolonged symptoms or diagnosable conditions following COVID-19 infection. The neuropsychiatric profile of Long COVID patients remains ambiguous. This study aimed to assess neuropsychiatric symptoms in a retrospective cohort of Long COVID patients (N = 162) at a Rehabilitation Medicine clinic in South Texas. Clinical data from patient records were used to calculate a Symptom Score, and screening tools for stress/PTSD (PCL-5), anxiety (GAD-7), and quality of life (SWL) were employed to evaluate if Long COVID duration and severity could predict neuropsychiatric outcomes. The majority were female (71%) and Hispanic (53%) who presented for treatment of Long COVID symptoms during the study period, including fatigue (93%), coughing/shortness of breath (81%), fever (67%), anosmia (58%), ageusia (54%), and weight loss (56%). There was a high burden of neuropsychiatric symptoms, including subjective cognitive impairment (79%), headache (74%), and insomnia (58%). Symptom Score (median = 9, IQR [8,11]) was significantly correlated with increased depression (PHQ-9; p < 0.05), anxiety (GAD-7; p < 0.05) and elevated stress/PTSD (PCL-5; p < 0.05) symptoms. Long COVID patients taking stimulants or mood stabilizers had higher GAD-7 (p < 0.031, p < 0.035) and PHQ-9 (p < 0.034, p < 0.009) scores but not PCL-5 scores. Importantly, duration of Long COVID symptomatology also did not predict PCL-5 scores. No patient factors (e.g., sex, age, BMI, ethnicity) mediated Symptom Score. Nonetheless, historically marginalized groups, such as women and Hispanics, have been disproportionately affected by COVID-19. This study is the first to utilize validates screening tools to determine the presence and severity of neuropsychiatric symptoms in Long COVID patients. These findings may guide clinical management and future research on Long COVID, especially in historically excluded populations.

Rehabilitation Medicine and Physical Therapy
Neurocognitive Impairment in Long COVID: A Systematic Review

Eugenia Panagea,Lambros Messinis,Maria Christina Petri,Ioannis Liampas,Emmanouil Anyfantis,Grigorios Nasios,Panayiotis Patrikelis,Mary Kosmidis

DOI: https://doi.org/10.1093/arclin/acae042

2024-06-08

Archives of Clinical Neuropsychology

Abstract:Abstract Objective Although Coronavirus disease 2019 (COVID-19) is primarily a respiratory infectious disease, it has also been associated with a wide range of other clinical manifestations. It is widely accepted in the scientific community that many patients after recovery continue to experience COVID-19-related symptoms, including cognitive impairment. The aim of this systematic review was to investigate the cognitive profile of patients with long-COVID syndrome. Methods A systematic search of empirical studies was conducted through the PubMed/Medline and Scopus electronic databases. Cross-sectional and longitudinal studies published between 2020 and 2023 were included. Results Of the 516 studies assessed for eligibility, 36 studies met the inclusion criteria. All included studies support the presence of persistent cognitive changes after COVID-19 disease. Executive function, memory, attention, and processing speed appear to be the cognitive domains that are predominantly associated with long-COVID syndrome, whereas language is an area that has not been sufficiently investigated. Conclusions In this review, the high frequency of cognitive impairment after COVID-19 is evident. If we consider that cognitive functioning affects our ability to live independently and is a key determinant of our quality of life, it is imperative to precisely define those factors that may induce cognitive impairment in COVID-19 survivors, with the ultimate goal of early diagnosis of cognitive changes and, consequently, the development of targeted rehabilitation interventions to address them.

psychology, clinical
Soybean Response to Ethylene Dibromide in a Soil Infested with Meloidogyne arenaria and Heterodera glycines.

D. Weaver,R. Rodríguez-kábana,E. Carden

1987-10-01

Journal of Nematology

Abstract:One susceptible and six nematode-resistant soybean cultivars were evaluated in the field for their effects on seed yield, nematode populations, and response to the fumigant nematicide, ethylene dibromide. The soil was a loamy sand infested with Meloidogyne arenaria and Heterodera glycines. Cultivars significantly affected yield and numbers of H. glycines but did not affect M. arenaria numbers. Fumigation increased yield and reduced M. arenaria numbers but did not affect numbers of H. glycines. The interaction between cultivars and fumigation was significant for yield but not for nematode numbers.
Long COVID in Brain Health Research: A Call to Action

Thorsten Rudroff

DOI: https://doi.org/10.3390/brainsci14060587

IF: 3.333

2024-06-09

Brain Sciences

Abstract:The COVID-19 pandemic has brought attention to the long-term consequences of the virus, particularly the persistent symptoms that characterize long COVID. This syndrome, which can last for months after the initial infection, includes a range of neurological and neuropsychiatric manifestations that have significant implications for brain health and dementia research. This review explores the current understanding of long COVID's cognitive, neurological, and psychiatric symptoms and their potential impact on brain stimulation and neuroimaging studies. It argues that researchers must adapt their study designs and screening processes to account for the confounding effects of long COVID and ensure the accuracy and reliability of their findings. To advance the understanding of this condition and its long-term effects on brain health, the review proposes a series of strategies, including the development of standardized screening tools, the investigation of underlying mechanisms, and the identification of risk factors and protective factors. It also emphasizes the importance of collaborative research efforts and international data sharing platforms in accelerating the pace of discovery and developing targeted interventions for individuals with long COVID. As the prevalence of this condition continues to grow, it is imperative that the neuroscience community comes together to address this challenge and support those affected by long COVID.

neurosciences
A Mixed Method Systematic Review

Nawar Diar Bakerly,Nikki Smith,Julie L. Darbyshire,Joseph Kwon,Emily Bullock,Sareeta Baley,Manoj Sivan,Brendan Delaney

DOI: https://doi.org/10.3390/ijerph21040473

IF: 4.614

2024-04-13

International Journal of Environmental Research and Public Health

Abstract:Introduction: Long COVID (LC) is a global public health crisis affecting more than 70 million people. There is emerging evidence of different pathophysiological mechanisms driving the wide array of symptoms in LC. Understanding the relationships between mechanisms and symptoms helps in guiding clinical management and identifying potential treatment targets. Methods: This was a mixed-methods systematic review with two stages: Stage one (Review 1) included only existing systematic reviews (meta-review) and Stage two (Review 2) was a review of all primary studies. The search strategy involved Medline, Embase, Emcare, and CINAHL databases to identify studies that described symptoms and pathophysiological mechanisms with statistical analysis and/or discussion of plausible causal relationships between mechanisms and symptoms. Only studies that included a control arm for comparison were included. Studies were assessed for quality using the National Heart, Lung, and Blood Institute quality assessment tools. Results: 19 systematic reviews were included in Review 1 and 46 primary studies in Review 2. Overall, the quality of reporting across the studies included in this second review was moderate to poor. The pathophysiological mechanisms with strong evidence were immune system dysregulation, cerebral hypoperfusion, and impaired gas transfer in the lungs. Other mechanisms with moderate to weak evidence were endothelial damage and hypercoagulation, mast cell activation, and auto-immunity to vascular receptors. Conclusions: LC is a complex condition affecting multiple organs with diverse clinical presentations (or traits) underpinned by multiple pathophysiological mechanisms. A 'treatable trait' approach may help identify certain groups and target specific interventions. Future research must include understanding the response to intervention based on these mechanism-based traits.

public, environmental & occupational health,environmental sciences
Lessons learned in implementing a multidisciplinary long COVID clinic

Ana Palacio,Elizabeth Bast,Nancy Klimas,Leonardo Tamariz

DOI: https://doi.org/10.1016/j.amjmed.2024.05.020

IF: 5.928

2024-05-23

The American Journal of Medicine

Abstract:The diagnosis and treatment of long COVID patients is challenging. Our aim is to share lessons learned using a multidisciplinary approach within the Veterans Affairs system. Our long COVID clinic is based in primary care but has imbedded rehabilitations specialists, nutrition. whole health and different specialists within internal medicine. We conduct an extensive work-up to evaluate the presence of end-organ damage, ongoing inflammation and dysautonomia. Our treatments are based on the prior experience that the VA system has on chronic fatigue syndrome and gulf war illness.

medicine, general & internal
Long COVID in long-term care: a rapid realist review

Ian Fyffe,Janice Sorensen,Simon Carroll,Maura MacPhee,Alison Andrews-Paul,Valorie A Crooks,Shannon Freeman,Karen Davison,Jennifer Walls,Annette Berndt,Benajir Shams,Manoj Sivan,Akber Mithani

DOI: https://doi.org/10.1136/bmjopen-2023-076186

IF: 3.006

2023-12-20

BMJ Open

Abstract:Objectives: The goals of this rapid realist review were to ask: (a) what are the key mechanisms that drive successful interventions for long COVID in long-term care (LTC) and (b) what are the critical contexts that determine whether the mechanisms produce the intended outcomes? Design: Rapid realist review. Data sources: Medline, CINAHL, Embase, PsycINFO and Web of Science for peer-reviewed literature and Google for grey literature were searched up to 23 February 2023. Eligibility criteria: We included sources focused on interventions, persons in LTC, long COVID or post-acute phase at least 4 weeks following initial COVID-19 infection and ones that had a connection with source materials. Data extraction and synthesis: Three independent reviewers searched, screened and coded studies. Two independent moderators resolved conflicts. A data extraction tool organised relevant data into context-mechanism-outcome configurations using realist methodology. Twenty-one sources provided 51 intervention data excerpts used to develop our programme theory. Synthesised findings were presented to a reference group and expert panel for confirmatory purposes. Results: Fifteen peer-reviewed articles and six grey literature sources were eligible for inclusion. Eleven context-mechanism-outcome configurations identify those contextual factors and underlying mechanisms associated with desired outcomes, such as clinical care processes and policies that ensure timely access to requisite resources for quality care delivery, and resident-centred assessments and care planning to address resident preferences and needs. The underlying mechanisms associated with enhanced outcomes for LTC long COVID survivors were: awareness, accountability, vigilance and empathetic listening. Conclusions: Although the LTC sector struggles with organisational capacity issues, they should be aware that comprehensively assessing and monitoring COVID-19 survivors and providing timely interventions to those with long COVID is imperative. This is due to the greater care needs of residents with long COVID, and coordinated efficient care is required to optimise their quality of life.
Deep Dive into the Long Haul: Analysis of Symptom Clusters and Risk Factors for Post-Acute Sequelae of COVID-19 to Inform Clinical Care

Nicole H. Goldhaber,Jordan N. Kohn,William Scott Ogan,Amy Sitapati,Christopher A. Longhurst,Angela Wang,Susan Lee,Suzi Hong,Lucy E. Horton

DOI: https://doi.org/10.3390/ijerph192416841

IF: 4.614

2022-12-15

International Journal of Environmental Research and Public Health

Abstract:Long COVID is a chronic condition characterized by symptoms such as fatigue, dyspnea, and cognitive impairment that persist or relapse months after an acute infection with the SARS-CoV-2 virus. Many distinct symptoms have been attributed to Long COVID; however, little is known about the potential clustering of these symptoms and risk factors that may predispose patients to certain clusters. In this study, an electronic survey was sent to patients in the UC San Diego Health (UCSDH) system who tested positive for COVID-19, querying if patients were experiencing symptoms consistent with Long COVID. Based on survey results, along with patient demographics reported in the electronic health record (EHR), linear and logistic regression models were used to examine putative risk factors, and exploratory factor analysis was performed to determine symptom clusters. Among 999 survey respondents, increased odds of Long COVID (n = 421; 42%) and greater Long COVID symptom burden were associated with female sex (OR = 1.73, 99% CI: 1.16–2.58; β = 0.48, 0.22–0.75), COVID-19 hospitalization (OR = 4.51, 2.50–8.43; β = 0.48, 0.17–0.78), and poorer pre-COVID self-rated health (OR = 0.75, 0.57–0.97; β = −0.19, −0.32–−0.07). Over one-fifth of Long COVID patients screened positive for depression and/or anxiety, the latter of which was associated with younger age (OR = 0.96, 0.94–0.99). Factor analysis of 16 self-reported symptoms suggested five symptom clusters—gastrointestinal (GI), musculoskeletal (MSK), neurocognitive (NC), airway (AW), and cardiopulmonary (CP), with older age (β = 0.21, 0.11–0.30) and mixed race (β = 0.27, 0.04–0.51) being associated with greater MSK symptom burden. Greater NC symptom burden was associated with increased odds of depression (OR = 5.86, 2.71–13.8) and anxiety (OR = 2.83, 1.36–6.14). These results can inform clinicians in identifying patients at increased risk for Long COVID-related medical issues, particularly neurocognitive symptoms and symptom clusters, as well as informing health systems to manage operational expectations on a population-health level.

public, environmental & occupational health,environmental sciences
Long COVID: cognitive, balance, and retina manifestations

Meritxell Carmona-Cervelló,Brenda Biaani León-Gómez,Rosalia Dacosta-Aguayo,Noemí Lamonja-Vicente,Pilar Montero-Alía,Gemma Molist,Aitana Ayet,Carla Chacón,Anna Costa-Garrido,Victor M. López-Lifante,Valeria Zamora-Putin,Liudmila Liutsko,Rosa García-Sierra,Antònia Fornés,Eduard Moreno-Gabriel,Marta Massanella,Jose A. Muñoz-Moreno,M. Carmen Rodríguez-Pérez,Lourdes Mateu,Anna Prats,Maria Mataró,Marc Boigues,Bibiana Quirant,Julia G. Prado,Eva Martínez-Cáceres,Concepción Violán,Pere Torán-Monserrat,

DOI: https://doi.org/10.3389/fmed.2024.1399145

IF: 3.9

2024-07-05

Frontiers in Medicine

Abstract:Background The neurological symptoms of Long COVID (LC) and the impact of neuropsychological manifestations on people’s daily lives have been extensively described. Although a large body of literature describes symptoms, validating this with objective measures is important. This study aims to identify and describe the effects of Long COVID on cognition, balance, and the retinal fundus, and determine whether the duration of symptoms influences cognitive impairment. Methods This cross-sectional study involved LC volunteers with cognitive complaint from public health centers in northern Barcelona who participated between January 2022 and March 2023. This study collected sociodemographic characteristics, information on substance use, comorbidities, and clinical data related to COVID-19. We measured five cognitive domains using a battery of neuropsychological tests. Balance was assessed through posturography and retinal vascular involvement by retinography. Results A total of 166 people with LC and cognitive complaints participated, 80.72% were women and mean age was 49.28 ± 8.39 years. The most common self-reported symptoms were concentration and memory deficit (98.80%), brain fog (82.53%) and insomnia (71.17%). The 68.67% presented cognitive deficit in at least one domain, with executive functions being the most frequent (43.98%). The 51.52% of the participants exhibited a dysfunctional pattern in balance, and 9.2% showed some alteration in the retina. There were no statistically significant differences between cognitive impairment and symptom duration. Conclusion Our findings contribute to a more comprehensive understanding of the pathology associated with Long COVID. They highlight the diversity of self-reported symptoms, the presence of abnormal balance patterns, and some cognitive impairment. These findings underscore the necessity of addressing the clinical management of this condition in primary care through follow-up and the pursuit of multidisciplinary and comprehensive treatment.

medicine, general & internal
Emerging trends in management of long COVID with a focus on pulmonary rehabilitation: A review

Allison Y. Li,Willis X. Li,Jinghong Li

DOI: https://doi.org/10.1111/crj.13777

2024-05-24

The Clinical Respiratory Journal

Abstract:This review provides a concise overview of long COVID, encompassing its definition, prevalence, mechanisms, clinical manifestations, diagnosis and management approaches. It emphasizes the significance of multidisciplinary approach in diagnosis and treatment of long COVID, with focus on pulmonary rehabilitation and innovative technology advances to effectively address the management of long COVID. Long COVID, or post‐acute sequelae of COVID‐19 (PASC), represents a complex condition with persistent symptoms following SARS‐Cov‐2 infection. The symptoms include fatigue, dyspnoea, cognitive impairment, decreased quality of life in variable levels of severity. Potential mechanisms behind long COVID include vascular damage, immune dysregulation and viral persistence. Diagnosing long COVID involves medical evaluation by multidisciplinary team and assessment of persistent symptoms with scoring systems in development. Treatment strategies are symptom‐focused, encompassing multidisciplinary care, rehabilitation and tailored exercise programmes. Pulmonary rehabilitation, an effective and critical component of long COVID management, has shown promise, particularly for patients with respiratory symptoms such as dyspnoea. These programmes, which combine exercise, breathing techniques, education and psychological support, improve symptoms, quality of life and overall recovery. Innovative technologies, such as telemedicine, wearable devices, telerehabilitation, are transforming long COVID management. Telemedicine facilitates consultations and interventions, eliminating healthcare access barriers. Wearable devices enable remote and continuous monitoring of patients during their rehabilitation activities. Telerehabilitation has proven to be safe and feasible and to have high potential for COVID‐19 recovery. This review provides a concise overview of long COVID, encompassing its definition, prevalence, mechanisms, clinical manifestations, diagnosis and management approaches. It emphasizes the significance of multidisciplinary approach in diagnosis and treatment of long COVID, with focus on pulmonary rehabilitation and innovative technology advances to effectively address the management of long COVID.

respiratory system
Insights into attention and memory difficulties in post-COVID syndrome using standardized neuropsychological tests and experimental cognitive tasks

Sandra Arbula,Elisabetta Pisanu,Giulia Bellavita,Alina Menichelli,Alberta Lunardelli,Giovanni Furlanis,Paolo Manganotti,Stefano Cappa,Raffaella Rumiati

DOI: https://doi.org/10.1038/s41598-024-54613-9

IF: 4.6

2024-02-23

Scientific Reports

Abstract:The COVID-19 pandemic has given rise to post-acute cognitive symptoms, often described as 'brain fog'. To comprehensively grasp the extent of these issues, we conducted a study integrating traditional neuropsychological assessments with experimental cognitive tasks targeting attention control, working memory, and long-term memory, three cognitive domains most commonly associated with 'brain fog'. We enrolled 33 post-COVID patients, all self-reporting cognitive difficulties, and a matched control group (N = 27) for cognitive and psychological assessments. Our findings revealed significant attention deficits in post-COVID patients across both neuropsychological measurements and experimental cognitive tasks, evidencing reduced performance in tasks involving interference resolution and selective and sustained attention. Mild executive function and naming impairments also emerged from the neuropsychological assessment. Notably, 61% of patients reported significant prospective memory failures in daily life, aligning with our recruitment focus. Furthermore, our patient group showed significant alterations in the psycho-affective domain, indicating a complex interplay between cognitive and psychological factors, which could point to a non-cognitive determinant of subjectively experienced cognitive changes following COVID-19. In summary, our study offers valuable insights into attention challenges faced by individuals recovering from COVID-19, stressing the importance of comprehensive cognitive and psycho-affective evaluations for supporting post-COVID individuals.

multidisciplinary sciences
Epidemiological and clinical perspectives of long COVID syndrome

Katherine Huerne,Kristian B Filion,Roland Grad,Pierre Ernst,Andrea S Gershon,Mark J Eisenberg

DOI: https://doi.org/10.1016/j.ajmo.2023.100033

Abstract:Long COVID, or post-acute COVID-19 syndrome, is characterized by multi-organ symptoms lasting 2+ months after initial COVID-19 virus infection. This review presents the current state of evidence for long COVID syndrome, including the global public health context, incidence, prevalence, cardiopulmonary sequelae, physical and mental symptoms, recovery time, prognosis, risk factors, rehospitalization rates, and the impact of vaccination on long COVID outcomes. Results are presented by clinically relevant subgroups. Overall, 10-35% of COVID survivors develop long COVID, with common symptoms including fatigue, dyspnea, chest pain, cough, depression, anxiety, post-traumatic stress disorder, memory loss, and difficulty concentrating. Delineating these issues will be crucial to inform appropriate post-pandemic health policy and protect the health of COVID-19 survivors, including potentially vulnerable or underrepresented groups. Directed to policymakers, health practitioners, and the general public, we provide recommendations and suggest avenues for future research with the larger goal of reducing harms associated with long COVID syndrome.
Transport advances in disposable bioreactors for liver tissue engineering.

G. Catapano,J. Patzer,J. Gerlach

DOI: https://doi.org/10.1007/10_2008_34

Advances in Biochemical Engineering/Biotechnology

Abstract:
Estimation of fault-free leakage current using wafer-level spatial information

S. Sabade,D. Walker

DOI: https://doi.org/10.1109/TVLSI.2005.863183

IEEE Transactions on Very Large Scale Integration (VLSI) Systems

Abstract:Leakage current or the I/sub DDQ/ test has been shown to be an effective test screen in combination with traditional test methods. However, leakage current is rising rapidly as semiconductor technology advances. This makes it difficult to distinguish between faulty and fault-free chips using traditional threshold setting methods. This paper presents a method to estimate leakage current using neighboring chip information on a wafer. Outlier chips are rejected, and a least-squares-fit plane through neighboring chips is used to estimate defect-free I/sub DDQ/. Chips that significantly deviate from the estimate are rejected. The proposed method is evaluated using industrial test data.
Sudden hyperpyrexia during general anesthesia.

N. Thomford,W. Hamelberg,W. Wiederholt

DOI: https://doi.org/10.1097/00132586-197104000-00026

IF: 4.348

1971-04-01

Surgery

Abstract:
Interplay between Comorbidities and Long COVID: Challenges and Multidisciplinary Approaches

Rasha Ashmawy,Esraa Abdellatif Hammouda,Yousra A El-Maradny,Iman Aboelsaad,Mai Hussein,Vladimir N Uversky,Elrashdy M Redwan

DOI: https://doi.org/10.3390/biom14070835

IF: 6.064

2024-07-11

Biomolecules

Abstract:Long COVID, a name often given to the persistent symptoms following acute SARS-CoV-2 infection, poses a multifaceted challenge for health. This review explores the intrinsic relationship between comorbidities and autoimmune responses in shaping the trajectory of long COVID. Autoantibodies have emerged as significant players in COVID-19 pathophysiology, with implications for disease severity and progression. Studies show immune dysregulation persisting months after infection, marked by activated innate immune cells and high cytokine levels. The presence of autoantibodies against various autoantigens suggests their potential as comorbid factors in long COVID. Additionally, the formation of immune complexes may lead to severe disease progression, highlighting the urgency for early detection and intervention. Furthermore, long COVID is highly linked to cardiovascular complications and neurological symptoms, posing challenges in diagnosis and management. Multidisciplinary approaches, including vaccination, tailored rehabilitation, and pharmacological interventions, are used for mitigating long COVID's burden. However, numerous challenges persist, from evolving diagnostic criteria to addressing the psychosocial impact and predicting disease outcomes. Leveraging AI-based applications holds promise in enhancing patient management and improving our understanding of long COVID. As research continues to unfold, unravelling the complexities of long COVID remains paramount for effective intervention and patient care.

[Spontaneous intracranial hypotension--a treatable cause of headache].

Neuropsychology practice guidance for the neuropsychiatric aspects of Long COVID

Long COVID neuropsychological follow-up: Is cognitive rehabilitation relevant?

A Practical Approach to Tailor the Term Long COVID for Diagnostics, Therapy and Epidemiological Research for Improved Long COVID Patient Care

A practical framework for Long COVID treatment in primary care

Assessing Neuropsychiatric Symptoms in Long COVID: A Retrospective Cohort Study from a South Texas Long COVID Clinic

Neurocognitive Impairment in Long COVID: A Systematic Review

Soybean Response to Ethylene Dibromide in a Soil Infested with Meloidogyne arenaria and Heterodera glycines.

Long COVID in Brain Health Research: A Call to Action

A Mixed Method Systematic Review

Lessons learned in implementing a multidisciplinary long COVID clinic

Long COVID in long-term care: a rapid realist review

Deep Dive into the Long Haul: Analysis of Symptom Clusters and Risk Factors for Post-Acute Sequelae of COVID-19 to Inform Clinical Care

Long COVID: cognitive, balance, and retina manifestations

Emerging trends in management of long COVID with a focus on pulmonary rehabilitation: A review

Insights into attention and memory difficulties in post-COVID syndrome using standardized neuropsychological tests and experimental cognitive tasks

Epidemiological and clinical perspectives of long COVID syndrome

Transport advances in disposable bioreactors for liver tissue engineering.

Estimation of fault-free leakage current using wafer-level spatial information

Sudden hyperpyrexia during general anesthesia.

Interplay between Comorbidities and Long COVID: Challenges and Multidisciplinary Approaches